Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav. 2002;71:533-554. (Pubitemid 34219205)
Passchier J, van Waarde A. Visualisation of serotonin-1A (5-HT1A) receptors in the central nervous system. Eur J Nucl Med. 2001;28:113-129. (Pubitemid 32120814)
Pike VW, Halldin C, Wikstrom HV. Radioligands for the study of brain 5-HT1A receptors in vivo. Prog Med Chem. 2001;38:189-247.
Aznavour N, Zimmer L. [ 18F]MPPF as a tool for the in vivo imaging of 5-HT1A receptors in animal and human brain. Neuropharmacology. 2007;52:695-707.
Kumar JS, Mann JJ. PET tracers for 5-HT(1A) receptors and uses thereof. Drug Discov Today. 2007;12:748-756. (Pubitemid 47364834)
Emerit MB, el Mestikawy S, Gozlan H, Rouot B, Hamon M. Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins. Biochem Pharmacol. 1990;39:7-18. (Pubitemid 20027964)
Kobilka B. Adrenergic receptors as models for G protein-coupled receptors. Annu Rev Neurosci. 1992;15:87-114.
Hall MD, el Mestikawy S, Emerit MB, Pichat L, Hamon M, Gozlan H. [ 3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J Neurochem. 1985;44:1685-1696.
Mongeau R, Welner SA, Quirion R, Suranyi-Cadotte BE. Further evidence for differential affinity states of the serotonin1A receptor in rat hippocampus. Brain Res. 1992;590:229-238.
Nénonéné EK, Radja F, Carli M, Grondin L, Reader TA. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin. J Neurochem. 1994;62:1822-1834. (Pubitemid 24121875)
Aznavour N, Rbah L, Leger L, et al. A comparison of in vivo and in vitro neuroimaging of 5-HT 1A receptor binding sites in the cat brain. J Chem Neuroanat. 2006;31:226-232.
Gozlan H, Ponchant M, Daval G, et al. 125I-Bolton-Hunter-8-methoxy-2-[N- propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies. J Pharmacol Exp Ther. 1988;244:751-759. (Pubitemid 18076625)
Mathis C, Huang Y, Simpson N. Synthesis and evaluation of 5HT1A agonists as radioligands: failure of G protein-coupled receptor agonists as in vivo imaging agents. J Labelled Comp Radiopharm. 1997;40(suppl):563-564.
Suehiro M, Underwood M, Arango V, et al. In vivo biodistribution of a radiotracer for imaging serotonin-1A receptor sites with PET: [11C]LY274601. Life Sci. 1998;63:1533-1542. (Pubitemid 28470718)
Fujio M, Nagata S, Kawamura K, et al. Synthesis and evaluation of 11C-labeled (S)-N-[[1-(2-phenylethyl) pyrrolidin-2-yl]methyl]-3- methylthiobenzamide as a PET 5-HT(1A) receptor ligand. Nucl Med Biol. 2002;29:657-663.
Matsubara S, Arora RC, Meltzer HY. Serotoninergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims. J Neural Transm. 1991;85:181-194.
Kumar JS, Prabhakaran J, Majo VJ, et al. Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl- 11C]2-(4- (4-(2-methoxyphenyl) piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine -3,5(2H,4H)dione in nonhuman primates. Eur J Nucl Med Mol Imaging. 2007;34:1050-1060.
Lu S, Liow JS, Zoghbi SS, Hong J, Innis RB, Pike VW. Evaluation of [C]S14506 and [F]S14506 in rat and monkey as agonist PET radioligands for brain 5-HT (1A) receptors. Curr Radiopharm. 2010;3:9-18.
Zimmer L, Fournet G, Benoit J, Guillaumet G, Le Bars D. Carbon-11 labelling of 8[[3-[4-(2-[ 11C]methoxyphenyl)piperazin-1-yl]-2- hydroxypropyl]oxy]thioch roman, a presynaptic 5-HT(1A) receptor agonist, and its in vivo evaluation in anaesthetised rat and in awake cat. Nucl Med Biol. 2003;30:541-546.
Milak MS, Severance AJ, Ogden RT, et al. Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET. J Nucl Med. 2008;49:587-596.
Milak MS, DeLorenzo C, Zanderigo F, et al. In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer. J Nucl Med. 2010;51:1892-1900.
Milak MS, Severance AJ, Prabhakaran J, et al. In vivo serotonin-sensitive binding of [ 11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer. J Cereb Blood Flow Metab. 2011;31:243-249.
Kumar JS, Majo VJ, Hsiung SC, et al. Synthesis and in vivo validation of [O-methyl- 11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]butyl} -4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand. J Med Chem. 2006;49:125-134.
Hendry N, Christie I, Rabiner EA, Laruelle M, Watson J. In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissue. Nucl Med Biol. 2011;38:273-277.
Maurel JL, Autin JM, Funes P, Newman-Tancredi A, Colpaert F, Vacher B. High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity. J Med Chem. 2007;50:5024-5033. (Pubitemid 47534045)
Jasper H, Ajmone-Marsan C. A Stereotaxic Atlas of the Diencephalon of the Cat. Ottawa, Canada: The National Research Council of Canada Editors; 1954.
Snyder R, Niemer W. A Stereotaxic Atlas of the Cat Brain. Chicago, Illinois: University of Chicago Press; 1961.
Assié MB, Lomenech H, Ravailhe V, Faucillon V, Newman-Tancredi A. Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat. Br J Pharmacol. 2006;149:170-178. (Pubitemid 44360098)
Vacher B, Bonnaud B, Funes P, et al. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors. J Med Chem. 1999;42:1648-1660. (Pubitemid 29226734)
Koek W, Vacher B, Cosi C, et al. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential. Eur J Pharmacol. 2001;420:103-112. (Pubitemid 32537684)
Bollinger S, Hubner H, Heinemann FW, Meyer K, Gmeiner P. Novel pyridylmethylamines as highly selective 5-HT(1A) superagonists. J Med Chem. 2010;53:7167-7179.
Lemoine L, Verdurand M, Vacher B, et al. [ 18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging. Eur J Nucl Med Mol Imaging. 2010;37:594-605.
Laruelle M, Slifstein M, Huang Y. Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography. Mol Imaging Biol. 2003;5:363-375. (Pubitemid 37489827)
Lanfumey L, Hamon M. 5-HT1 receptors. Curr Drug Targets CNS Neurol Disord. 2004;3:1-10.
Zimmer L, Pain F, Mauger G, et al. The potential of the beta-Microprobe, an intracerebral radiosensitive probe, to monitor the [ 18F]MPPF binding in the rat dorsal raphe nucleus. Eur J Nucl Med Mol Imaging. 2002;29:1237-1247.
Mannoury la Cour C, El Mestikawy S, Hanoun N, Hamon M, Lanfumey L. Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Mol Pharmacol. 2006;70:1013-1021. (Pubitemid 44268458)
Newman-Tancredi A, Martel JC, Assie MB, et al. Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist. Br J Pharmacol. 2009;156:338-353.
Khawaja X. Quantitative autoradiographic characterisation of the binding of [ 3H] WAY-100635, a selective 5-HT1A receptor antagonist. Brain Res. 1995;673:217-225.
